Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 24;9(9):CD012871.
doi: 10.1002/14651858.CD012871.pub2.

Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies

George U Eleje  1 , Ahizechukwu C Eke  2 , Joseph I Ikechebelu  3 , Ifeanyichukwu U Ezebialu  4 , Princeston C Okam  5 , Chito P Ilika  5
Affiliations

Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies

George U Eleje et al. Cochrane Database Syst Rev. .

Abstract

Background: Preterm birth (PTB) remains the foremost global cause of perinatal morbidity and mortality. Thus, the prevention of spontaneous PTB still remains of critical importance. In an attempt to prevent PTB in singleton pregnancies, cervical cerclage, in combination with other treatments, has been advocated. This is because, cervical cerclage is an intervention that is commonly recommended in women with a short cervix at high risk of preterm birth but, despite this, many women still deliver prematurely, as the biological mechanism is incompletely understood. Additionally, previous Cochrane Reviews have been published on the effectiveness of cervical cerclage in singleton and multiple pregnancies, however, none has evaluated the effectiveness of using cervical cerclage in combination with other treatments.

Objectives: To assess whether antibiotics administration, vaginal pessary, reinforcing or second cerclage placement, tocolytic, progesterone, or other interventions at the time of cervical cerclage placement prolong singleton gestation in women at high risk of pregnancy loss based on prior history and/or ultrasound finding of 'short cervix' and/or physical examination. History-indicated cerclage is defined as a cerclage placed usually between 12 and 15 weeks gestation based solely on poor prior obstetrical history, e.g. multiple second trimester losses due to painless dilatation. Ultrasound-indicated cerclage is defined as a cerclage placed usually between 16 and 23 weeks gestation for transvaginal ultrasound cervical length < 20 mm in a woman without cervical dilatation. Physical exam-indicated cerclage is defined as a cerclage placed usually between 16 and 23 weeks gestation because of cervical dilatation of one or more centimetres detected on physical (manual) examination.

Search methods: We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) (26 September 2019), and reference lists of retrieved studies.

Selection criteria: We included published, unpublished or ongoing randomised controlled trial (RCTs). Studies using a cluster-RCT design were also eligible for inclusion in this review but none were identified. We excluded quasi-RCTs (e.g. those randomised by date of birth or hospital number) and studies using a cross-over design. We also excluded studies that specified addition of the combination therapy after cervical cerclage because the woman subsequently became symptomatic. We included studies comparing cervical cerclage in combination with one, two or more interventions with cervical cerclage alone in singleton pregnancies.

Data collection and analysis: Two review authors independently screened titles and abstracts of all retrieved articles, selected studies for inclusion, extracted data, assessed risk of bias, and evaluated the certainty of the evidence for this review's main outcomes. Data were checked for accuracy. Standard Cochrane review methods were used throughout.

Main results: We identified two studies (involving a total of 73 women) comparing cervical cerclage alone to a different comparator. We also identified three ongoing studies (one investigating vaginal progesterone after cerclage, and two investigating cerclage plus pessary). One study (20 women), conducted in the UK, comparing cervical cerclage in combination with a tocolytic (salbutamol) with cervical cerclage alone in women with singleton pregnancy did not provide any useable data for this review. The other study (involving 53 women, with data from 50 women) took place in the USA and compared cervical cerclage in combination with a tocolytic (indomethacin) and antibiotics (cefazolin or clindamycin) versus cervical cerclage alone - this study did provide useable data for this review (and the study authors also provided additional data on request) but meta-analyses were not possible. This study was generally at a low risk of bias, apart from issues relating to blinding. We downgraded the certainty of evidence for serious risk of bias and imprecision (few participants, few events and wide 95% confidence intervals). Cervical cerclage in combination with an antibiotic and tocolytic versus cervical cerclage alone (one study, 50 women/babies) We are unclear about the effect of cervical cerclage in combination with antibiotics and a tocolytic compared with cervical cerclage alone on the risk of serious neonatal morbidity (RR 0.62, 95% CI 0.31 to 1.24; very low-certainty evidence); perinatal loss (data for miscarriage and stillbirth only - data not available for neonatal death) (RR 0.46, 95% CI 0.13 to 1.64; very low-certainty evidence) or preterm birth < 34 completed weeks of pregnancy (RR 0.78, 95% CI 0.44 to 1.40; very low-certainty evidence). There were no stillbirths (intrauterine death at 24 or more weeks). The trial authors did not report on the numbers of babies discharged home healthy (without obvious pathology) or on the risk of neonatal death.

Authors' conclusions: Currently, there is insufficient evidence to evaluate the effect of combining a tocolytic (indomethacin) and antibiotics (cefazolin/clindamycin) with cervical cerclage compared with cervical cerclage alone for preventing spontaneous PTB in women with singleton pregnancies. Future studies should recruit sufficient numbers of women to provide meaningful results and should measure neonatal death and numbers of babies discharged home healthy, as well as other important outcomes listed in this review. We did not identify any studies looking at other treatments in combination with cervical cerclage. Future research needs to focus on the role of other interventions such as vaginal support pessary, reinforcing or second cervical cerclage placement, 17-alpha-hydroxyprogesterone caproate or dydrogesterone or vaginal micronised progesterone, omega-3 long chain polyunsaturated fatty acid supplementation and bed rest.

Trial registration: ClinicalTrials.gov NCT00787813 NCT03837288 NCT02678026 NCT02846909.

PubMed Disclaimer

Conflict of interest statement

George U Eleje: none known. Joseph I Ikechebelu: none known. Ahizechukwu C Eke: none known. Princeston C Okam: none known. Ifeanyichukwu U Ezebialu: none known. Chito P Ilika: none known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3
3
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
1.1
1.1. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 1: Serious neonatal morbidity
1.2
1.2. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 2: Perinatal loss: all ‐ including miscarriages and stillbirth (but no data for neonatal death)
1.3
1.3. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 3: Stillbirth (intrauterine fetal death at 24 weeks or more)
1.4
1.4. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 4: Miscarriages (perinatal loss before 24 weeks)
1.5
1.5. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 5: Preterm birth < 28 weeks
1.6
1.6. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 6: Preterm birth < 34 weeks
1.7
1.7. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 7: Preterm birth < 37 weeks
1.8
1.8. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 8: Serious intracranial pathology
1.9
1.9. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 9: Serious respiratory morbidity
1.10
1.10. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 10: Necrotising enterocolitis
1.11
1.11. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 11: Retinopathy of prematurity
1.12
1.12. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 12: Maternal infection, including chorioamnionitis, requiring intervention (chorioamnionitis)
1.13
1.13. Analysis
Comparison 1: Cervical cerclage in combination with antibiotic and tocolytic versus cervical cerclage alone, Outcome 13: Preterm premature rupture of membranes
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD012871

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Miller 2014 {published data only}
    1. Miller ES, Grobman WA, Fonseca L, Robinson B. The role in emergent cerclage of indomethacin and antibiotics (RECIA). American Journal of Obstetrics and Gynecology 2014;210(1 Suppl 1):S25. [CENTRAL: CN-01012126] [EMBASE: 71275416]
    1. Miller ES, Grobman WA, Fonseca L, Robinson BK. Indomethacin and antibiotics in examination-indicated cerclage. Obstetrics & Gynecology 2014;123:1311-6. - PubMed
    1. NCT01114516. Multifactorial approach to emergent cerclage [Role in emergent cerclage of indomethacin and antibiotics]. clinicaltrials.gov/show/NCT01114516 (first received 29 Apr 2010). [CENTRAL: CN-02026479]
Toplis 1980 {published data only}
    1. Toplis PJ, Shepherd JH, Youssefmejadian E, Jakubowicz D, Dewhurst J. Plasma prostaglandin concentrations after cerclage in early pregnancy. British Journal of Obstetrics and Gynaecology 1980;87:669-71. - PubMed

References to studies excluded from this review

Althuisius 2002 {published data only}
    1. Althuisius S, Dekker G, Hummel P, Bekedam D, Kuik D, Vn Geijn H. Cervical Incompetence Prevention RAndomized Cerclage Trial (CIPRACT): effect of therapeutic cerclage with bed rest vs. bed rest only on cervical length. Ultrasound in Obstetrics & Gynecology 2002;20(2):163-7. [PMID: ] - PubMed
Barinov 2017 {published data only}
    1. Barinov SV, Shamina IV, Lazareva OV, Tirskaya YI, Ralko VV, Shkabarnya LL, et al. Comparative assessment of arabin pessary, cervical cerclage and medical management for preterm birth prevention in high-risk pregnancies. Journal of Maternal-Fetal & Neonatal Medicine 2017;30(15):1841-6. - PubMed
Berghella 2010 {published data only}
    1. Berghella V, Figueroa D, Szychowski JM, Owen J, Hankins GD, Iams JD, et al. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. American Journal of Obstetrics and Gynecology 2010;202(4):351.e1-6. [PMID: ] - PMC - PubMed
Berghella 2017 {published data only}
    1. Berghella V, Owen J, Szychowski JM. Outcomes with cerclage alone compared with cerclage plus 17alpha-hydroxyprogesterone caproate. Obstetrics and Gynecology 2017;129(2):390-1. [PMID: ] - PubMed
Deutinger 1992 {published data only}
    1. Deutinger J, Rudelstorfer R, Pattermann A, Bernaschek G. Vaginosonographic velocimetry in uterine arteries before and after administration of beta-mimetics. British Journal of Obstetrics and Gynaecology 1992;99:417-21. - PubMed
Enakpene 2018 {published data only}
    1. Enakpene CA, DiGiovanni L, Jones TN, Marshalla M, Mastrogiannis D, Della Torre M. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening. American Journal of Obstetrics and Gynecology 2018;219(4):397.e1-397.e10. [PMID: ] - PubMed
Endl 1982 {published data only}
    1. Endl J, Baumgarten K. Results of prophylactic oral long term tocolysis and cerclage for the prolongation of twin pregnancy (a multi-center study) [Uber die ergebnisse der prophylaktischen oralen langzeittokolyse und cerclage zur verlangerung der zwillingsschwangerschaften (eine multicenterstudie)]. Zeitschrift fur Geburtshilfe und Perinatologie 1982;186:319-25. - PubMed
Ionescu 2012 {published data only}
    1. Ionescu AC, Gheorghiu D, Pacu I, Davitoiu B, Dimitriu M, Haradja H. Randomized trial of cerclage and progesterone to prevent spontaneous preterm birth in high-risk women with a short cervix. Journal of Perinatal Medicine 2012;39 Suppl:Abstract no. 008.
Jung 2016 {published data only}
    1. Jung EY, Oh KJ, Hong JS, Han BR, Joo JK. Addition of adjuvant progesterone to physical-exam-indicated cervical cerclage to prevent preterm birth. Journal of Obstetrics and Gynaecology Research 2016;42(12):1666-72. [PMID: ] - PubMed
Keeler 2009 {published data only}
    1. Keeler SM, Kiefer D, Rochon M, Quinones JN, Novetsky AP, Rust O. A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix. Journal of Perinatal Medicine 2009;37(5):473-9. [PMID: ] - PubMed
Mackeen 2013 {published data only}
    1. Mackeen AD, Rafael TJ, Zavodnick J, Berghella V. Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage. American Journal of Perinatology 30;9:755-8. - PubMed
Nasr 2011 {published data only}
    1. NCT00787813. N-acetyl cysteine after cervical cerclage (NAC-CC). clinicaltrials.gov/ct2/show/record/NCT00787813 (first received 10 November 2008).
    1. Nasr A, Saman A, Zakherah M. Effect of oral N-acetyl cysteine on pregnancy outcome after cervical cerclage: a randomized controlled trial. Fertility and Sterility 2011;96(3 Suppl 1):S32.
NCT03837288 {published data only}
    1. NCT03837288. Cervical cerclage for singleton pregnant on vaginal progesterone with progressive cervical length shortening. clinicaltrials.gov/ct2/show/NCT03837288 (first received 12 February 2019).
Pustotina 2018 {published data only}
    1. Pustotina O. Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix. Journal of Maternal-fetal & Neonatal Medicine 2018;31(14):1830-8. [PMID: ] - PubMed
Rafael 2011 {published data only}
    1. Rafael TJ, Mackeen AD, Berghella V. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage. American Journal of Perinatology 2011;28(5):389-94. - PubMed
Ragab 2015 {published data only}
    1. Ragab A, Mesbah Y. To do or not to emergency cervical cerclage (a rescue stitch) at 24-28 weeks gestation in addition to progesterone for patients coming early in labor? A prospective randomized trial for efficacy and safety. Archives of Gynecology and Obstetrics 2015;292:1255-60. - PubMed
Rebarber 2008 {published data only}
    1. Rebarber A, Cleary-Goldman J, Istwan NB, Rhea DJ, Desch C, Russo-Stieglitz K, et al. The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage. American Journal of Perinatology 2008;25(5):271-5. [PMID: ] - PubMed
Roman 2018 {published data only}
    1. Roman AR, Da Silva Costa F, Araujo Junior E, Sheehan PM. Rescue adjuvant vaginal progesterone may improve outcomes in cervical cerclage failure. Geburtshilfe und Frauenheilkunde 2018;78(8):785-90. [PMID: ] - PMC - PubMed
Samson 2018 {published data only}
    1. Samson FD, Merriman AL, Tate DL, Apostolakis-Kyrus K, Gomez LM. Adjuvant administration of 17-α-hydroxy-progesterone caproate in women with three or more second trimester pregnancy losses undergoing cervical cerclage is no more effective than cerclage alone. Journal of Perinatal Medicine 2018;46(2):155-61. - PubMed
Sinkey 2018 {published data only}
    1. Sinkey RG, Garcia MR, Odibo AO. Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth? Journal of Maternal-fetal & Neonatal Medicine 31;2:202-8. - PubMed
Stetson 2016 {published data only}
    1. Stetson B, Hibbard JU, Wilkins I, Leftwich H. Outcomes with cerclage alone compared with cerclage plus 17α-hydroxyprogesterone caproate. Obstetrics and Gynecology 2016;128(5):983-8. - PubMed
Szychowski 2012 {published data only}
    1. Szychowski JM, Berghella V, Owen J, Hankins G, Iams JD, Sheffield JS, et al. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-alpha-hydroxyprogesterone caproate. Journal of Maternal-fetal & Neonatal Medicine 2012;25(12):2686-9. [PMID: ] - PMC - PubMed
Yemini 1985 {published data only}
    1. Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, et al. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. American Journal Obstetrics and Gynecology 1985;151:574-7. - PubMed

References to ongoing studies

IRTC20180302038914N1 {published data only}
    1. IRCT20180302038914N1. Comparing efficacy of cerclage and adjunctive therapy (cerclage & pessary) in prevention of preterm birth in pregnant women with cervical incompetence. en.irct.ir/trial/30016 (first received 7 May 2018).
NCT02678026 {published data only}
    1. NCT02678026. Pessary as adjunctive therapy to cerclage for the prevention of preterm birth. clinicaltrials.gov/ct2/show/record/NCT02678026 (first received 9 February 2016).
NCT02846909 {published data only}
    1. NCT02846909. The effect of adjunctive use of vaginal progesterone after cerclage on prevention of 2nd trimester miscarriage. clinicaltrials.gov/ct2/show/record/NCT02846909 (first received 27 July 2016). [NCT02846909]

Additional references

Abdel‐Aleem 2013
    1. Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No: CD007873. [DOI: 10.1002/14651858.CD007873.pub3] - DOI - PMC - PubMed
Abdulaziz 2015
    1. Abdulaziz M, Stothers L, Lazare D, Macnab A. An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse. Canadian Urological Association Journal: Journal de l'Association des Urologues du Canada 2015;9(5-6):E400-6. [PMID: ] - PMC - PubMed
ACOG 2003
    1. ACOG. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstetrics and Gynecology 2003;101(5 Pt 1):1039-47. [PMID: ] - PubMed
ACOG 2014
    1. Anon. ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstetrics and Gynecology 2014;123(2 Pt 1):372-9. [PMID: ] - PubMed
Alfirevic 2017
    1. Alfirevic Z, Stampalija T, Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No: CD008991. [DOI: 10.1002/14651858.CD008991.pub3] - DOI - PMC - PubMed
Alijahan 2014
    1. Alijahan R, Hazrati S, Mirzarahimi M, Pourfarzi F, Ahmadi Hadi P. Prevalence and risk factors associated with preterm birth in Ardabil, Iran. Iranian Journal of Reproductive Medicine 2014;12(1):47-56. [PMID: ] - PMC - PubMed
Allen 2001
    1. Allen KG, Harris MA. The role of n-3 fatty acids in gestation and parturition. Experimental Biology and Medicine 2001;226(6):498-506. [PMID: ] - PubMed
Althuisius 2000
    1. Althuisius SM, Dekker GA, Van Geijn HP, Bekedam DJ, Hummel P. Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results. American Journal of Obstetrics and Gynecology 2000;183(4):823-9. [PMID: ] - PubMed
Althuisius 2003
    1. Althuisius SM, Dekker GA, Hummel P, Van Geijn HP. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. American Journal of Obstetrics and Gynecology 2003;189(4):907-10. [PMID: ] - PubMed
Andrews 2006
    1. Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial. American Journal of Obstetrics and Gynecology 2006;194(3):617-23. [PMID: ] - PubMed
Antczak‐Judycka 2003
    1. Antczak-Judycka A, Sawicki W, Spiewankiewicz B, Cendrowski K, Stelmachow J. Comparison of cerclage and cerclage pessary in the treatment of pregnant women with incompetent cervix and threatened preterm delivery [Porownanie skutecznosci leczenia szwem szyjkowym oraz pessarium kolnierzowym szyjki macicy u ciezarnych z niewydolnoscia ciesniowo-szyjkowa i zagrazajacym porodem przedwczesnym]. Ginekologia Polska 2003;74(10):1029-36. [PMID: ] - PubMed
Arabin 2003
    1. Arabin B, Halbesma JR, Vork F, Hubener M, Van Eyck J. Is treatment with vaginal pessaries an option in patients with a sonographically detected short cervix? Journal of Perinatal Medicine 2003;31(2):122-33. [PMID: ] - PubMed
Asiegbu 2020
    1. Asiegbu AC, Eleje GU, Ibeneme EM, Onyegbule OA, Chukwu LC, Egwim AV, et al. Combined insulin-like growth factor binding protein-1/interleukin-6 (Premaquick) versus fetal fibronectin for predicting preterm delivery among women with preterm contractions. International Journal of Gynaecology and Obstetrics 2020;149(2):171-7. [PMID: ] - PubMed
Azem 2004
    1. Azem F, Blaucher A, Many A. Complications of early elective cervical cerclage. International Journal of Gynaecology and Obstetrics 2004;85(1):52-3. [PMID: ] - PubMed
Barbosa 2020
    1. Barbosa M, Bek Helmig R, Hvidman L. Twin pregnancies treated with emergency or ultrasound-indicated cerclage to prevent preterm births. Journal of Maternal-fetal & Neonatal Medicine 2020;33(19):3227-32. [PMID: ] - PubMed
Baxter 2005
    1. Baxter JK, Airoldi J, Berghella V. Short cervical length after history-indicated cerclage: is a reinforcing cerclage beneficial? American Journal of Obstetrics and Gynecology 2005;193(3 Pt 2):1204-7. [PMID: ] - PubMed
Becher 2009
    1. Becher N, Adams Waldorf K, Hein M, Uldbjerg N. The cervical mucus plug: structured review of the literature. Acta Obstetricia et Gynecologica Scandinavica 2009;88(5):502-13. [PMID: ] - PubMed
Berghella 2006
    1. Berghella V, Rust OA, Althuisius SM. Short cervix on ultrasound: does indomethacin prevent preterm birth? American Journal of Obstetrics and Gynecology 2006;195(3):809-13. [PMID: ] - PubMed
Berghella 2009
    1. Berghella V, Prasertcharoensuk W, Cotter A, Rasanen J, Mittal S, Chaithongwongwatthana S, et al. Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester? American Journal of Perinatology 2009;26(1):13-9. [PMID: ] - PubMed
Blencowe 2012
    1. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379(9832):2162-72. [PMID: ] - PubMed
Blencowe 2013
    1. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, et al. Born too soon: the global epidemiology of 15 million preterm births. Reproductive Health 2013;10 Suppl 1:S2. [PMID: ] - PMC - PubMed
Caritis 2014
    1. Caritis SN, Venkataramanan R, Thom E, Harper M, Klebanoff MA, Sorokin Y, et al. Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth. American Journal of Obstetrics and Gynecology 2014;210(2):128.e1-6. [PMID: ] - PMC - PubMed
Castanon 2015
    1. Castanon A, Landy R, Brocklehurst P, Evans H, Peebles D, Singh N, et al. Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment? BJOG 2015;122(9):1191-9. [DOI: 10.1111/1471-0528.13398] [PMID: ] - DOI - PMC - PubMed
CDC 2014
    1. Preterm Birth. Reproductive Health. www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm) (accessed in 2015).
Chang 2013
    1. Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, Cairns-Smith S, et al. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet 2013;381(9862):223-34. [PMID: ] - PMC - PubMed
Chughtai 2012
    1. Chughtai B, Spettel S, Kurman J, De E. Ambulatory pessary trial unmasks occult stress urinary incontinence. Obstetrics and Gynecology International 2012;2012:392027. [PMID: ] - PMC - PubMed
Conde‐Agudelo 2013
    1. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O'Brien JM, Cetingoz E, et al. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. American Journal of Obstetrics and Gynecology 2013;208(1):42.e1-18. [PMID: ] - PMC - PubMed
Cram 2002
    1. Cram LF, Zapata MI, Toy EC, Baker B 3rd. Genitourinary infections and their association with preterm labor. American Family Physician 2002;65(2):241-8. [PMID: ] - PubMed
Crowther 2014
    1. Crowther CA, Brown J, McKinlay CJ, Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews 2014, Issue 8. Art. No: CD001060. [DOI: 10.1002/14651858.CD001060.pub2] - DOI - PMC - PubMed
Dabi 2017
    1. Dabi Y, Nedellec S, Bonneau C, Trouchard B, Rouzier R, Benachi A. Clinical validation of a model predicting the risk of preterm delivery. PlOS One 2017;12(2):e0171801. [PMID: ] - PMC - PubMed
Defranco 2013
    1. Defranco EA, Valent AM, Newman T, Regan J, Smith J, Muglia LJ. Adjunctive therapies to cerclage for the prevention of preterm birth: a systematic review. Obstetrics and Gynecology International 2013;2013:528158. [PMID: ] - PMC - PubMed
Devane 2007
    1. Devane D, Begley CM, Clarke M, Horey D, OBoyle C. Evaluating maternity care: a core set of outcome measures. Birth 2007;34(2):164-72. [PMID: ] - PubMed
Dodd 2013
    1. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No: CD004947. [DOI: 10.1002/14651858.CD004947.pub3] - DOI - PMC - PubMed
Durnwald 2009
    1. Durnwald CP, Lynch CD, Walker H, Iams JD. The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. American Journal of Obstetrics and Gynecology 2009;201(4):410.e1-5. [PMID: ] - PMC - PubMed
Eke 2016
    1. Eke AC, Chalaan T, Shukr G, Eleje GU, Okafor CI. A systematic review and meta-analysis of progestogen use for maintenance tocolysis after preterm labor in women with intact membranes. International Journal of Gynecology and Obstetrics 2016;132(1):11-6. - PMC - PubMed
Eke 2019a
    1. Eke AC, Sheffield J, Graham EM. Adjuvant 17-hydroxyprogesterone caproate in women with history-indicated cerclage: a systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 2019;98(2):139-53. [PMID: ] - PMC - PubMed
Eke 2019b
    1. Eke AC, Sheffield J, Graham EM. 17α-hydroxyprogesterone caproate and the risk of glucose intolerance in pregnancy: a systematic review and meta-analysis. Obstetrics and Gynecology 2019;133(3):59-64. - PMC - PubMed
Eke 2019c
    1. Eke AC, Dooley KE, Sheffield JS. Pharmacologic research in pregnant women - time to get it right. New England Journal of Medicine 2019;380(14):1293-5. - PMC - PubMed
Eleje 2014
    1. Eleje GU, Adinma JI, Ghasi S, Ikechebelu JI, Igwegbe AO, Okonkwo JE, et al. Antibiotic susceptibility pattern of genital tract bacteria in pregnant women with preterm premature rupture of membranes in a resource-limited setting. International Journal of Gynecology and Obstetrics 2014;127(1):10-4. [PMID: ] - PubMed
Eleje 2015a
    1. Eleje GU, Adinma JI, Ugwuanyi DC, Ikechebelu JI, Okafor CI, Ezeama CO, et al. Genital tract microbial isolate in women with preterm pre-labour rupture of membranes in resource-constrained community setting. Journal of Obstetrics and Gynaecology 2015;35(5):465-8. [PMID: ] - PubMed
Eleje 2015b
    1. Eleje GU, Ezugwu EC, Ogunyemi D, Eleje LI, Ikechebelu JI, Igwegbe AO, et al. Accuracy and cost-analysis of placental alpha-microglobulin-1 test in the diagnosis of premature rupture of fetal membranes in resource-limited community settings. Journal of Obstetrics and Gynaecology Research 2015;41(1):29-38. [PMID: ] - PubMed
Eleje 2017
    1. Eleje GU, Ezugwu EC, Eke AC, Eleje LI, Ikechebelu JI, Ezebialu IU, et al. Accuracy of a combined insulin-like growth factor-binding protein-1/interleukin-6 test (Premaquick) in predicting delivery in women with threatened preterm labor. Journal of Perinatal Medicine 2017;45(8):915-24. [PMID: ] - PubMed
Eleje 2020
    1. Eleje GU, Ukah CO, Onyiaorah IV, Ezugwu EC, Ugwu EO, Ohayi SR, et al. Diagnostic value of Chorioquick for detecting chorioamnionitis in women with premature rupture of membranes. International Journal of Gynaecology and Obstetrics 2020;149(1):98-105. [PMID: ] - PubMed
Espinoza 2006
    1. Espinoza J, Erez O, Romero R. Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. American Journal of Obstetrics and Gynecology 2006;194(3):630-7. [PMID: ] - PubMed
Facchinetti 2007
    1. Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. American Journal of Obstetrics and Gynecology 2007;196(5):453.e1-4, 421. [PMID: ] - PubMed
Farr 2015
    1. Farr A, Kiss H, Hagmann M, Marschalek J, Husslein P, Petricevic L. Routine use of an antenatal infection screen-and-treat program to prevent preterm birth: long-term experience at a tertiary referral center. Birth 2015;42(2):173-80. [DOI: 10.1111/birt.12154] [PMID: ] - DOI - PubMed
Flenady 2013
    1. Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No: CD000246. [DOI: 10.1002/14651858.CD000246.pub2] - DOI - PMC - PubMed
Flenady 2014
    1. Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No: CD002255. [DOI: 10.1002/14651858.CD002255.pub2] - DOI - PMC - PubMed
Fonseca 2007
    1. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. New England Journal of Medicine 2007;357(5):462-9. [PMID: ] - PubMed
Fox 1998
    1. Fox R, Holmes R, James M, Tuohy J, Wardle P. Serial transvaginal ultrasonography following McDonald cerclage and repeat suture insertion. Australian & New Zealand Journal of Obstetrics & Gynaecology 1998;38(1):27-30. [PMID: ] - PubMed
Fox 2009
    1. Fox NS, Gelber SE, Kalish RB, Chasen ST. The recommendation for bed rest in the setting of arrested preterm labor and premature rupture of membranes. American Journal of Obstetrics and Gynecology 2009;200(2):165.e1-6. [PMID: ] - PubMed
Gibbs 1992
    1. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. American Journal of Obstetrics and Gynecology 1992;166:1515–28. - PubMed
Goldenberg 1994
    1. Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW, Mennemeyer ST. Bed rest in pregnancy. Obstetrics and Gynecology 1994;84(1):131-6. [PMID: ] - PubMed
Goldenberg 2008
    1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371(9606):75-84. [PMID: ] - PMC - PubMed
Gomez 1998
    1. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. American Journal of Obstetrics and Gynecology 1998;179(1):194-202. [PMID: ] - PubMed
Goncalves 2002
    1. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Mental Retardation and Developmental Disabilities Research Reviews 2002;8:3-13. - PubMed
Goya 2012
    1. Goya M, Pratcorona L, Merced C, Rodo C, Valle L, Romero A, et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012;379(9828):1800-6. [PMID: ] - PubMed
Gravett 1994
    1. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. American Journal of Obstetrics and Gynecology 1994;171(6):1660-7. [PMID: ] - PubMed
Harper 2010
    1. Harper M, Thom E, Klebanoff MA, Thorp J Jr, Sorokin Y, Varner MW, et al. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstetrics and Gynecology 2010;115(2 Pt 1):234-42. [PMID: ] - PMC - PubMed
Hershkovitz 2008
    1. Hershkovitz R, Burstein E, Pinku A. Tightening McDonald cerclage suture under sonographic guidance. Ultrasound in Obstetrics & Gynecology 2008;31(2):194-7. [PMID: ] - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Hollier 2005
    1. Hollier LM. Preventing preterm birth: what works, what doesn't. Obstetrical & Gynecological Survey 2005;60(2):124-31. [PMID: ] - PubMed
Hosny 2017
    1. Hosny AE, El-Khayat W, Kashef MT, Fakhry MN. Association between preterm labor and genitourinary tract infections caused by Trichomonas vaginalis, Mycoplasma hominis, Gram-negative bacilli, and coryneforms. Journal of the Chinese Medical Association 2017;80(9):575-81. [PMID: ] - PubMed
Ioscovich 2015
    1. Ioscovich A, Popov A, Gimelfarb Y, Gozal Y, Orbach-Zinger S, Shapiro J, et al. Anesthetic management of prophylactic cervical cerclage: a retrospective multicenter cohort study. Archives of Gynecology and Obstetrics 2015;291(3):509-12. [PMID: ] - PubMed
Jongen 1997
    1. Jongen VH, Van Roosmalen J. Complications of cervical cerclage in rural areas. International Journal of Gynecology and Obstetrics 1997;57(1):23-6. [PMID: ] - PubMed
Kataoka 2006
    1. Kataoka S, Yamada T, Chou K, Nishida R, Morikawa M, Minami M, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. Journal of Clinical Microbiology 2006;44(1):51-5. [PMID: ] - PMC - PubMed
Kenyon 2001
    1. Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 2001;357(9261):989-94. [PMID: ] - PubMed
Lai 2009
    1. Lai SK, Wang YY, Wirtz D, Hanes J. Micro- and macrorheology of mucus. Advanced Drug Delivery Reviews 2009;61(2):86-100. [PMID: ] - PMC - PubMed
Lamont 2005
    1. Lamont RF. Can antibiotics prevent preterm birth - the pro and con debate. BJOG 2005;112 Suppl 1:67-73. [PMID: ] - PubMed
Lawn 2005
    1. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? where? why? Lancet 2005;365(9462):891-900. [PMID: ] - PubMed
Lichter 2019
    1. Lichter KE, Sheffield J, Graham EM, Eke AC. Adjuvant 17-hydroxyprogesterone caproate in women with ultrasound-indicated cerclage: a systematic review and meta-analysis. Journal of Maternal-fetal & Neonatal Medicine 2019;1:18-22. [DOI: 10.1080/14767058.2019.1568406] - DOI - PMC - PubMed
Liem 2013
    1. Liem SM, Van Pampus MG, Mol BW, Bekedam DJ. Cervical pessaries for the prevention of preterm birth: a systematic review. Obstetrics and Gynecology International 2013;2013:576723. [PMID: ] - PMC - PubMed
Likis 2012
    1. Likis FE, Edwards DR, Andrews JC, Woodworth AL, Jerome RN, Fonnesbeck CJ, et al. Progestogens for preterm birth prevention: a systematic review and meta-analysis. Obstetrics and Gynecology 2012;120(4):897-907. [PMID: ] - PubMed
Liu 2012
    1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012;379(9832):2151-61. [PMID: ] - PubMed
Maloni 2010
    1. Maloni JA. Antepartum bed rest for pregnancy complications: efficacy and safety for preventing preterm birth. Biological Research for Nursing 2010;12(2):106-24. [PMID: ] - PubMed
Manuck 2016
    1. Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, et al. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. American Journal of Obstetrics and Gynecology 2016;214(3):376.e1-8. [PMID: ] - PMC - PubMed
Manuck 2016a
    1. Manuck TA, Stoddard GJ, Fry RC, Esplin MS, Varner MW. Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system. American Journal of Obstetrics and Gynecology 2016;215(5):622.e1-8. [PMID: ] - PMC - PubMed
Marlow 2012
    1. Marlow N. Full term; an artificial concept. Archives of Disease in Childhood. Fetal and Neonatal Edition 2012;97(3):F158-9. [PMID: ] - PubMed
Mazor 1998
    1. Mazor M, Chaim W, Maymon E, Hershkowitz R, Romero R. The role of antibiotic therapy in the prevention of prematurity. Clinical Perinatology 1998;25:659-85. - PubMed
McDonald 1957
    1. McDonald IA. Suture of the cervix for inevitable miscarriage. Journal of Obstetrics and Gynaecology of the British Empire 1957;64(3):346-50. [PMID: ] - PubMed
Meis 2003
    1. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. New England Journal of Medicine 2003;348(24):2379-85. [PMID: ] - PubMed
MRC/RCOG 1993
    1. MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. British Journal of Obstetrics and Gynaecology 1993;100(6):516-23. [PMID: ] - PubMed
Nelson 2017
    1. Nelson DB, McIntire DD, McDonald J, Gard J, Turrichi P, Leveno KJ. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study. American Journal of Obstetrics and Gynecology 2017;216(6):600.e1-9. [PMID: ] - PMC - PubMed
Newcomer 2000
    1. Newcomer J. Pessaries for the treatment of incompetent cervix and premature delivery. Obstetrical & Gynecological Survey 2000;55(7):443-8. [PMID: ] - PubMed
Newnham 2014
    1. Newnham JP, Dickinson JE, Hart RJ, Pennell CE, Arrese CA, Keelan JA. Strategies to prevent preterm birth. Frontiers in Immunology 2014;5:584. [PMID: ] - PMC - PubMed
Ning 2017
    1. Ning A, Vladutiu CJ, Dotters-Katz SK, Goodnight WH, Manuck TA. Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth. American Journal of Obstetrics and Gynecology 2017;217(3):371.e1-7. [PMID: ] - PubMed
Novy 1987
    1. Novy MJ, Ducsay CA, Stanczyk FZ. Plasma concentrations of prostaglandin F2 alpha and prostaglandin E2 metabolites after transabdominal and transvaginal cervical cerclage. American Journal of Obstetrics and Gynecology 1987;156:1543-52. - PubMed
Odibo 2007
    1. Odibo AO, Berghella V, To MS, Rust OA, Althuisius SM, Nicolaides KH. Shirodkar versus McDonald cerclage for the prevention of preterm birth in women with short cervical length. American Journal of Perinatology 2007;24(1):55-60. [PMID: ] - PubMed
Olsen 2000
    1. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C, Fish Oil Trials In Pregnancy (FOTIP) Team. Randomised clinical trials of fish oil supplementation in high risk pregnancies. BJOG 2000;107(3):382-95. [PMID: ] - PubMed
Olsen 2007
    1. Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition 2007;61(8):976-85. [PMID: ] - PubMed
Owen 2009
    1. Owen J, Hankins G, Iams JD, Berghella V, Sheffield JS, Perez-Delboy A, et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. American Journal of Obstetrics and Gynecology 2009;201(4):375.e1-8. [PMID: ] - PMC - PubMed
O’Brien 2009
    1. O’Brien JM, DeFranco EA, Adair CD, Lewis DF, Hall DR, How H, et al. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasound in Obstetrics & Gynecology 2009;34:653-9. - PubMed
Patro‐Malysza 2009
    1. Patro-Malysza J, Leszczynska-Gorzelak B, Marciniak B, Bartosiewicz J, Oleszczuk J. The use of pessaries in the treatment of incompetent cervix [Zastosowanie pessarow w leczeniu niewydolnosci ciesniowo-szyjkowej]. Ginekologia Polska 2009;80(1):54-8. [PMID: ] - PubMed
Petrou 2003
    1. Petrou S, Mehta Z, Hockley C, Cook-Mozaffari P, Henderson J, Goldacre M. The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life. Pediatrics 2003;112(6 Pt 1):1290-7. [PMID: ] - PubMed
Petrou 2005
    1. Petrou S. The economic consequences of preterm birth during the first 10 years of life. BJOG 2005;112 Suppl 1:10-5. [PMID: ] - PubMed
Pustotina 2017
    1. Pustotina O. Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix. Journal of Maternal-Fetal & Neonatal Medicine 2017;31(14):1830-8. [PMID: ] - PubMed
Rafael 2014
    1. Rafael TJ, Berghella V, Alfirevic Z. Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy. Cochrane Database of Systematic Reviews 2014, Issue 9. Art. No: CD009166. [DOI: 10.1002/14651858.CD009166.pub2] - DOI - PMC - PubMed
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Romero 1998
    1. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. American Journal of Obstetrics and Gynecology 1998;179(1):186-93. [PMID: ] - PubMed
Romero 2013
    1. Romero R, Yeo L, Miranda J, Hassan SS, Conde-Agudelo A, Chaiworapongsa T. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. Journal of Perinatal Medicine 2013;41(1):27-44. [PMID: ] - PMC - PubMed
Romero 2014a
    1. Romero R, Yeo L, Chaemsaithong P, Chaiworapongsa T, Hassan SS. Progesterone to prevent spontaneous preterm birth. Seminars in Fetal & Neonatal Medicine 2014;19(1):15-26. [PMID: ] - PMC - PubMed
Romero 2014b
    1. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345(6198):760-5. [PMID: ] - PMC - PubMed
Rush 1984
    1. Rush RW, Isaacs S, McPherson K, Jones L, Chalmers I, Grant A. A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery. British Journal of Obstetrics and Gynaecology 1984;91(8):724-30. [PMID: ] - PubMed
Saccone 2015a
    1. Saccone G, Berghella V. Omega-3 supplementation to prevent recurrent preterm birth: a systematic review and metaanalysis of randomized controlled trials. American Journal of Obstetrics and Gynecology 2015;213(2):135-40. [PMID: ] - PubMed
Saccone 2015b
    1. Saccone G, Rust O, Althuisius S, Roman A, Berghella V. Cerclage for short cervix in twin pregnancies: systematic review and meta-analysis of randomized trials using individual patient-level data. Acta Obstetricia et Gynecologica Scandinavica 2015;94(4):352-8. [PMID: ] - PubMed
Saccone 2015c
    1. Saccone G, Berghella V. Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth: a systematic review and meta-analysis. Obstetrics and Gynecology 2015;125(3):663-72. [PMID: ] - PubMed
Sadowsky 2006
    1. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. American Journal of Obstetrics and Gynecology 2006;195(6):1578-89. [PMID: ] - PubMed
Sanborn 1995
    1. Sanborn BM. Ion channels and the control of myometrial electrical activity. Seminars in Perinatology 1995;19(1):31-40. [PMID: ] - PubMed
Sangkomkamhang 2015
    1. Sangkomkamhang US, Lumbiganon P, Prasertcharoensuk W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database of Systematic Reviews 2015, Issue 2. Art. No: CD006178. [DOI: 10.1002/14651858.CD006178.pub3] - DOI - PMC - PubMed
Shirodkar 1955
    1. Shirodkar VN. A new method of operative treatment for habitual abortions in the second trimester of pregnancy. Antiseptic 1955;52:299-300.
Simcox 2007
    1. Simcox R, Shennan A. Cervical cerclage: a review. International Journal of Surgery 2007;5(3):205-9. [PMID: ] - PubMed
Simonazzi 2015
    1. Simonazzi G, Curti A, Bisulli M, Seravalli V, Saccone G, Berghella V. Cervical lacerations in planned versus labor cerclage removal: a systematic review. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2015;193:19-22. [PMID: ] - PubMed
Slager 2012
    1. Slager J, Lynne S. Treatment options and recommendations to reduce preterm births in women with short cervix. Journal of Midwifery & Women's Health 2012;57 Suppl 1:S12-8. [PMID: ] - PubMed
Smith 2009
    1. Smith V, Devane D, Begley CM, Clarke M, Higgins S. A systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2009;142(1):3-11. [PMID: ] - PubMed
Smith 2015
    1. Smith J, DeFranco EA. Tocolytics used as adjunctive therapy at the time of cerclage placement: a systematic review. Journal of Perinatology 2015;35(8):561-5. [PMID: ] - PubMed
Sosa 2015
    1. Sosa CG, Althabe F, Belizan JM, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No: CD003581. [DOI: 10.1002/14651858.CD003581.pub3] - DOI - PMC - PubMed
Spong 2007
    1. Spong CY. Prediction and prevention of recurrent spontaneous preterm birth. Obstetrics and Gynecology 2007;110(2 Pt 1):405-15. [PMID: ] - PubMed
Tan 2006
    1. Tan TC, Devendra K, Tan LK, Tan HK. Tocolytic treatment for the management of preterm labour: a systematic review. Singapore Medical Journal 2006;47(5):361-6. [PMID: ] - PubMed
Teitelman 1990
    1. Teitelman AM, Welch LS, Hellenbrand KG, Bracken MB. Effect of maternal work activity on preterm birth and low birth weight. American Journal of Epidemiology 1990;131(1):104-13. [PMID: ] - PubMed
Tita 2007
    1. Tita AT, Cliver SP, Goepfert AR, Conner M, Goldenberg RL, Hauth JC, et al. Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction. American Journal of Obstetrics and Gynecology 2007;197(4):367.e1-6. [PMID: ] - PubMed
Umeigbo 2020
    1. Umeigbo BC, Modebe IA, Iloghalu IC, Eleje GU, Okoro CC, Umeononihu OS, et al. Outcomes of preterm labor and preterm births: a retrospective cross-sectional analytical study in a Nigerian single center population. Obstetrics and Gynecology Research 2020;3(1):17-28.
Van 't Hooft 2016
    1. Van 't Hooft J, Duffy JM, Daly M, Williamson PR, Meher S, Thom E, et al. A core outcome set for evaluation of interventions to prevent preterm birth. Obstetrics and Gynecology 2016;127(1):49-58. [PMID: ] - PMC - PubMed
Van Vliet 2014
    1. Van Vliet EO, Boormans EM, De Lange TS, Mol BW, Oudijk MA. Preterm labor: current pharmacotherapy options for tocolysis. Expert Opinion on Pharmacotherapy 2014;15(6):787-97. [PMID: ] - PubMed
Vidaeff 2009
    1. Vidaeff AC, Ramin SM. Management strategies for the prevention of preterm birth: Part II - Update on cervical cerclage. Current Opinion in Obstetrics & Gynecology 2009;21(6):485-90. [PMID: ] - PubMed
Visintine 2008
    1. Visintine J, Airoldi J, Berghella V. Indomethacin administration at the time of ultrasound-indicated cerclage: is there an association with a reduction in spontaneous preterm birth? American Journal of Obstetrics and Gynecology 2008;198(6):643.e1-3. [PMID: ] - PubMed
Vitoratos 1996
    1. Vitoratos N, Hassiakos D, Louridas C, Limuris G, Zourlas PA. Prostaglandin F1a and prostaglandin E2 plasma levels after transvaginal cervical cerclage. Clinical and Experimental Obstetrics & Gynecology 1996;23:21-5. - PubMed
Vogel 2014
    1. Vogel JP, Nardin JM, Dowswell T, West HM, Oladapo OT. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No: CD006169. [DOI: 10.1002/14651858.CD006169.pub2] - DOI - PMC - PubMed
WHO 1977
    1. WHO. Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Acta Obstetricia et Gynecologica Scandinavica 1977;56:247-53. - PubMed
Yoon 2008
    1. Yoon HJ, Hong JY, Kim SM. The effect of anesthetic method for prophylactic cervical cerclage on plasma oxytocin: a randomized trial. International Journal of Obstetric Anesthesia 2008;17(1):26-30. [PMID: ] - PubMed
Yorifuji 2014
    1. Yorifuji T, Makino S, Yamamoto Y, Tanaka T, Itakura A, Takeda S. Effectiveness of delayed absorbable monofilament suture in emergency cerclage. Taiwanese Journal of Obstetrics & Gynecology 2014;53(3):382-4. [PMID: ] - PubMed

References to other published versions of this review

Eleje 2017a
    1. Eleje GU, Ikechebelu JI, Eke AC, Okam PC, Ezebialu IU, Ilika CP. Cervical cerclage in combination with other treatments for preventing preterm birth in singleton pregnancies. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No: CD012871. [DOI: 10.1002/14651858.CD012871] - DOI - PMC - PubMed

Publication types

Associated data

LinkOut - more resources